Daniel Shevrin to Biomarkers, Tumor
This is a "connection" page, showing publications Daniel Shevrin has written about Biomarkers, Tumor.
Connection Strength
0.129
-
Genomic predictors for treatment of late stage prostate cancer. Asian J Androl. 2016 Jul-Aug; 18(4):586-91.
Score: 0.075
-
Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway). Clin Cancer Res. 2024 Oct 01; 30(19):4318-4328.
Score: 0.033
-
Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012. J Clin Oncol. 2018 04 01; 36(10):991-999.
Score: 0.021